Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,467 results for ""Pyrimethamine""

Your Filters

Subject : malaria, falciparum
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo.

  • Authors : Djontu JC; Fondation Congolaise pour la Recherche Médicale, Brazzaville, Congo; Biotechnology Center, University of Yaounde I, Yaounde, Cameroon. Electronic address: .

Subjects: Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/drug effects ; Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/genetics ; Pyrimethamine*/Pyrimethamine*/Pyrimethamine*/pharmacology

  • Source: International journal for parasitology. Drugs and drug resistance [Int J Parasitol Drugs Drug Resist] 2024 Dec; Vol. 26, pp. 100569. Date of Electronic Publication: 2024 Oct 26.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101576715 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012-2022.

  • Authors : Zhou R; Department of Parasite Disease Control and Prevention, Henan Provincial Key Laboratory of Pathogenic Microbiology, Henan Provincial Medical Key Laboratory of Parasitic Diseases and Vector, Henan Province Center for Disease Control and Prevention, Zhengzhou, People's Republic of China.; Li S

Subjects: Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/drug effects ; Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/genetics ; Pyrimethamine*/Pyrimethamine*/Pyrimethamine*/pharmacology

  • Source: Scientific reports [Sci Rep] 2024 Nov 04; Vol. 14 (1), pp. 26567. Date of Electronic Publication: 2024 Nov 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.

  • Authors : Juliano JJ; Division of Infectious Diseases, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Curriculum of Genetics and Molecular Biology, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Antimalarials*/Antimalarials*/Antimalarials*/pharmacology ; Drug Resistance*/Drug Resistance*/Drug Resistance*/genetics

  • Source: The Lancet. Microbe [Lancet Microbe] 2024 Oct; Vol. 5 (10), pp. 100920. Date of Electronic Publication: 2024 Aug 16.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Cameroon.

  • Authors : Martinez-Vega R; Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. .; Mbacham WF

Subjects: Pyrimethamine*/Pyrimethamine*/Pyrimethamine*/therapeutic use ; Pyrimethamine*/Pyrimethamine*/Pyrimethamine*/administration & dosage ; Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/therapeutic use

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Sep 26; Vol. 24 (1), pp. 1028. Date of Electronic Publication: 2024 Sep 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Evidence on sulfadoxine-pyrimethamine resistance molecular markers from India: interpret with caution.

  • Authors : Deora N; ICMR-National Institute of Malaria Research, New Delhi, India.; Sinha A

Subjects: Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/pharmacology ; Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/therapeutic use ; Pyrimethamine*/Pyrimethamine*/Pyrimethamine*/pharmacology

  • Source: Malaria journal [Malar J] 2024 Jul 24; Vol. 23 (1), pp. 219. Date of Electronic Publication: 2024 Jul 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Seasonal malaria chemoprevention and the spread of Plasmodium falciparum quintuple-mutant parasites resistant to sulfadoxine-pyrimethamine: a modelling study.

  • Authors : Masserey T; Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.

Subjects: Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/therapeutic use ; Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/pharmacology ; Pyrimethamine*/Pyrimethamine*/Pyrimethamine*/pharmacology

  • Source: The Lancet. Microbe [Lancet Microbe] 2024 Sep; Vol. 5 (9), pp. 100892. Date of Electronic Publication: 2024 Jul 09.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali.

  • Authors : Mahamar A; Malaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali. Electronic address: .; Smit MJ

Subjects: Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Antimalarials*/Antimalarials*/Antimalarials*/administration & dosage ; Drug Combinations*

  • Source: The Lancet. Microbe [Lancet Microbe] 2024 Jul; Vol. 5 (7), pp. 633-644. Date of Electronic Publication: 2024 May 02.Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Trend of N86Y and Y184F Mutations in Pfmdr1 Gene in Children Under Seasonal Malaria Chemoprevention Coverage in Nanoro, Burkina Faso.

  • Authors : Millogo KS; Institut de Recherche en Sciences de la Santé (IRSS)/ Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso. .; Kaboré B

Subjects: Multidrug Resistance-Associated Proteins*/Multidrug Resistance-Associated Proteins*/Multidrug Resistance-Associated Proteins*/genetics ; Antimalarials*/Antimalarials*/Antimalarials*/therapeutic use ; Antimalarials*/Antimalarials*/Antimalarials*/pharmacology

  • Source: Acta parasitologica [Acta Parasitol] 2024 Dec; Vol. 69 (4), pp. 1967-1976. Date of Electronic Publication: 2024 Oct 02.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 9301947 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Sustained clinical benefit of malaria chemoprevention with sulfadoxine-pyrimethamine (SP) in pregnant women in a region with high SP resistance markers.

Subjects: Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/therapeutic use ; Sulfadoxine*/Sulfadoxine*/Sulfadoxine*/administration & dosage ; Pyrimethamine*/Pyrimethamine*/Pyrimethamine*/therapeutic use

  • Source: The Journal of infection [J Infect] 2024 May; Vol. 88 (5), pp. 106144. Date of Electronic Publication: 2024 Apr 02.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Systematic Review and Geospatial Modeling of Molecular Markers of Resistance to Artemisinins and Sulfadoxine-Pyrimethamine in Plasmodium falciparum in India.

  • Authors : Nain M; ICMR-National Institute of Malaria Research, New Delhi, India.; Dhorda M

Subjects: Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/genetics ; Plasmodium falciparum*/Plasmodium falciparum*/Plasmodium falciparum*/drug effects ; Pyrimethamine*/Pyrimethamine*/Pyrimethamine*/therapeutic use

  • Source: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2024 Apr 02; Vol. 110 (5), pp. 910-920. Date of Electronic Publication: 2024 Apr 02 (Print Publication:Publisher: American Society of Tropical Medicine and Hygiene Country of Publication: United States NLM ID: 0370507 Publication Model: Electronic-Print Cited

Record details

Read More Add to Saved list
×
  • 1-10 of  1,467 results for ""Pyrimethamine""